| mm7008e3 |
First month of COVID-19 vaccine safety (Dec 2020–Jan 2021) |
First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021 |
| mm7018e2 |
Janssen COVID-19 vaccine safety (Mar–Apr 2021) |
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021 |
| mm7031e1 |
Adolescent Pfizer safety ages 12–17 (Dec 2020–Jul 2021) |
COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021 |
| mm7039e4 |
Additional dose safety (Aug–Sep 2021) |
Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021 |
| mm705152a1 |
Pfizer primary series ages 5–11 (Nov–Dec 2021) |
COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 |
| mm7107e1 |
Adult booster doses (Sep 2021–Feb 2022) |
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022 |
| mm7109e2 |
Booster doses ages 12–17 (Dec 2021–Feb 2022) |
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022 |
| mm7128a3 |
Immunocompromised dose-4 booster (Jan–Mar 2022) |
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years With Presumed Immunocompromise Status — United States, January 12–March 28, 2022 |
| mm7130a4 |
Second booster ages ≥50 (Mar–Jul 2022) |
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29–July 10, 2022 |
| mm7133a3 |
Pfizer booster ages 5–11 (May–Jul 2022) |
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022 |
| mm7135a3 |
mRNA primary series ages 6 mo–5 y (Jun–Aug 2022) |
COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18–August 21, 2022 |
| mm7144a3 |
Bivalent booster ages ≥12 (Aug–Oct 2022) |
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022 |
| mm7202a5 |
Bivalent booster ages 5–11 (Oct 2022–Jan 2023) |
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023 |
| mm7223a2 |
mRNA third dose ages 6 mo–5 y (Jun 2022–May 2023) |
Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023 |